Pfizer (PFE)
(Delayed Data from NYSE)
$29.42 USD
-0.24 (-0.81%)
Updated Sep 20, 2024 04:01 PM ET
After-Market: $29.40 -0.02 (-0.07%) 7:58 PM ET
2-Buy of 5 2
B Value F Growth C Momentum D VGM
Balance Sheet
Fiscal Year End for Pfizer Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 12,690 | 22,732 | 31,069 | 12,221 | 9,830 |
Receivables | 11,177 | 10,952 | 11,479 | 7,930 | 8,724 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 10,189 | 8,981 | 9,059 | 8,046 | 8,283 |
Other Current Assets | 9,277 | 8,594 | 8,086 | 6,869 | 5,965 |
Total Current Assets | 43,333 | 51,259 | 59,693 | 35,067 | 32,803 |
Net Property & Equipment | 18,940 | 16,274 | 14,882 | 13,900 | 13,967 |
Investments & Advances | 15,368 | 15,069 | 21,526 | 20,262 | 20,147 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 3,706 | 6,693 | 3,341 | 2,383 | 2,099 |
Intangibles | 132,683 | 94,745 | 74,354 | 78,048 | 94,023 |
Deposits & Other Assets | 12,471 | 13,163 | 7,679 | 4,569 | 4,450 |
Total Assets | 226,501 | 197,205 | 181,476 | 154,229 | 167,489 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 2,945 | 2,241 | 2,703 | 16,195 |
Accounts Payable | 6,710 | 6,809 | 5,578 | 4,309 | 4,220 |
Current Portion Long-Term Debt | 10,350 | 2,945 | 2,241 | 2,703 | 16,195 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 2,776 | 3,407 | 3,332 | 3,058 | 2,720 |
Income Taxes Payable | 2,349 | 1,587 | 1,266 | 1,049 | 980 |
Other Current Liabilities | 25,609 | 27,391 | 30,255 | 14,802 | 13,187 |
Total Current Liabilities | 47,794 | 42,138 | 42,671 | 25,920 | 37,304 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 640 | 1,023 | 349 | 4,063 | 5,578 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 61,538 | 32,884 | 36,195 | 37,133 | 35,955 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 27,240 | 25,242 | 24,798 | 23,640 | 25,205 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 137,213 | 101,288 | 104,013 | 90,756 | 104,042 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 17 |
Common Stock (Par) | 478 | 476 | 473 | 470 | 468 |
Capital Surplus | 92,631 | 91,802 | 90,591 | 88,674 | 87,428 |
Retained Earnings | 118,353 | 125,656 | 103,394 | 96,770 | 97,670 |
Other Equity | -7,687 | -8,048 | -5,635 | -11,453 | -11,337 |
Treasury Stock | 114,487 | 113,969 | 111,361 | 110,988 | 110,801 |
Total Shareholder's Equity | 89,288 | 95,916 | 77,462 | 63,473 | 63,447 |
Total Liabilities & Shareholder's Equity | 226,501 | 197,205 | 181,476 | 154,229 | 167,489 |
Total Common Equity | 89,288 | 95,916 | 77,462 | 63,473 | 63,430 |
Shares Outstanding | 5,646.40 | 5,613.30 | 5,612.80 | 5,558.40 | 5,534.10 |
Book Value Per Share | 15.81 | 17.09 | 13.80 | 11.42 | 11.46 |
Fiscal Year End for Pfizer Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 7,100 | 11,928 | 12,690 | 44,181 | 44,785 |
Receivables | 11,393 | 10,989 | 11,177 | 11,086 | 10,231 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 11,447 | 10,892 | 10,189 | 10,204 | 10,310 |
Other Current Assets | 7,884 | 8,605 | 9,277 | 8,541 | 8,022 |
Total Current Assets | 37,825 | 42,415 | 43,333 | 74,012 | 73,347 |
Net Property & Equipment | 18,957 | 18,803 | 18,940 | 17,862 | 17,488 |
Investments & Advances | 11,148 | 11,613 | 15,368 | 14,239 | 15,066 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 7,867 | 4,942 | 3,706 | 8,350 | 8,261 |
Intangibles | 129,685 | 132,126 | 132,683 | 91,751 | 92,978 |
Deposits & Other Assets | 10,710 | 11,197 | 12,471 | 8,808 | 13,028 |
Total Assets | 216,193 | 221,095 | 226,501 | 215,021 | 220,168 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 3,985 |
Accounts Payable | 5,106 | 5,591 | 6,710 | 5,338 | 6,081 |
Current Portion Long-Term Debt | 11,944 | 8,232 | 10,350 | 2,548 | 3,985 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 2,566 | 2,192 | 2,776 | 2,372 | 1,972 |
Income Taxes Payable | 2,884 | 3,192 | 2,349 | 1,898 | 2,928 |
Other Current Liabilities | 21,318 | 21,290 | 25,609 | 18,980 | 19,680 |
Total Current Liabilities | 43,819 | 40,497 | 47,794 | 31,136 | 34,647 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 2,227 | 931 | 640 | 1,125 | 1,232 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 57,506 | 61,307 | 61,538 | 61,048 | 61,356 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 24,667 | 27,240 | 24,507 | 23,639 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 128,218 | 128,537 | 137,213 | 117,817 | 120,875 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 480 | 480 | 478 | 478 | 478 |
Capital Surplus | 93,197 | 92,997 | 92,631 | 92,496 | 92,329 |
Retained Earnings | 116,596 | 121,318 | 118,353 | 126,411 | 128,796 |
Other Equity | -7,541 | -7,482 | -7,687 | -7,696 | -7,828 |
Treasury Stock | 114,757 | 114,755 | 114,487 | 114,485 | 114,482 |
Total Shareholder's Equity | 87,975 | 92,558 | 89,288 | 97,204 | 99,293 |
Total Liabilities & Shareholder's Equity | 216,193 | 221,095 | 226,501 | 215,021 | 220,168 |
Total Common Equity | 87,975 | 92,558 | 89,288 | 97,204 | 99,293 |
Shares Outstanding | 5,666.50 | 5,662.50 | 5,646.40 | 5,645.90 | 5,645.30 |
Book Value Per Share | 15.53 | 16.35 | 15.81 | 17.22 | 17.59 |